» Articles » PMID: 32850544

Rare Cases of Pediatric Vasoactive Intestinal Peptide Secreting Tumor With Literature Review: A Challenging Etiology of Chronic Diarrhea

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2020 Aug 28
PMID 32850544
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Vasoactive intestinal peptide (VIP) secreting tumor (VIPoma) is a rare disease, presenting with profuse diarrhea, electrolyte imbalance, and possibly fatal outcome. The diagnosis and treatment are challenging, and no consensus guideline of management is available. The pediatric incidence remains unclear. This study comprises two pediatric case reports from a tertiary center and a literature-based case series investigating the characteristics among children. The two reported cases both presented with severe diarrhea and laboratory abnormalities, including electrolyte imbalance and elevated plasma VIP level. Case 1 received several imaging investigations, partial pancreatectomy, octreotide, and everolimus, reflecting her complicated and refractory course. Case 2 underwent total excision of suprarenal ganglioneuroblastoma, and the clinical response was significant. In both cases, varied degrees of symptomatic control, reduced plasma VIP level, and correction of electrolyte imbalance were achieved. A literature review-based case series analyzed 45 pediatric cases retrieved from the PubMed database until December 31, 2019. Demographics, clinical features, diagnostic modalities, treatments, and outcomes were presented.

Citing Articles

Chronic diarrhea related to neuroblastoma: the important role of vasoactive intestinal peptide in tumor pathology and survival.

Cao M, Zhang K, Guo J, Dong F, Xu L BMC Cancer. 2025; 25(1):457.

PMID: 40082825 PMC: 11905442. DOI: 10.1186/s12885-025-13870-1.


Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma.

Thomas J, Peters N, Sekar A, Bansal D, Singh J, Kanojia R J Indian Assoc Pediatr Surg. 2024; 29(6):627-629.

PMID: 39691933 PMC: 11649041. DOI: 10.4103/jiaps.jiaps_104_24.


Vasoactive Intestinal Peptide-Producing Neuroblastic Tumors: A Rare Cause of Refractory Diarrhea.

Dornelles Penteado Pacheco E Silva L, Monteiro Caran E Cureus. 2024; 16(8):e67861.

PMID: 39328672 PMC: 11424392. DOI: 10.7759/cureus.67861.


Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor.

Belei O, Basaca D, Heredea E, Iacob E, Olariu L, Folescu R Life (Basel). 2023; 13(10).

PMID: 37895355 PMC: 10608053. DOI: 10.3390/life13101974.


Could the burden of pancreatic cancer originate in childhood?.

Diaconescu S, Gilca-Blanariu G, Poamaneagra S, Marginean O, Paduraru G, Stefanescu G World J Gastroenterol. 2021; 27(32):5322-5340.

PMID: 34539135 PMC: 8409163. DOI: 10.3748/wjg.v27.i32.5322.

References
1.
Scheibel E, Rechnitzer C, Fahrenkrug J, Hertz H . Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours. Acta Paediatr Scand. 1982; 71(5):721-5. DOI: 10.1111/j.1651-2227.1982.tb09510.x. View

2.
Kudo K, Kitajima S, Munakata H, Yagihashi S . WDHA syndrome caused by VIP-producing ganglioneuroblastoma. J Pediatr Surg. 1982; 17(4):426-8. DOI: 10.1016/s0022-3468(82)80507-1. View

3.
Rescorla F, Vane D, Fitzgerald J, West K, Grosfeld J . Vasoactive intestinal polypeptide-secreting ganglioneuromatosis affecting the entire colon and rectum. J Pediatr Surg. 1988; 23(7):635-7. DOI: 10.1016/s0022-3468(88)80634-1. View

4.
Angelousi A, Koffas A, Grozinsky-Glasberg S, Gertner J, Kassi E, Alexandraki K . Diagnostic and Management Challenges in Vasoactive Intestinal Peptide Secreting Tumors: A Series of 15 Patients. Pancreas. 2019; 48(7):934-942. DOI: 10.1097/MPA.0000000000001347. View

5.
Carson D, Glasgow J, Ardill J . Watery diarrhoea and elevated vasoactive intestine polypeptide associated with a massive neurofibroma in early childhood. J R Soc Med. 1980; 73(1):69-72. PMC: 1440026. DOI: 10.1177/014107688007300117. View